XML 73 R49.htm IDEA: XBRL DOCUMENT v3.19.1
Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2018
Equity [Abstract]  
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan
The following table summarizes our compensation costs recognized in General and administrative expense (excluding depreciation) and Operating expense (excluding depreciation) under the Incentive Plan and Stock Purchase Plan (in thousands):
 
Years Ended December 31,
 
2018
 
2017
 
2016
Restricted Stock Awards
$
3,483

 
$
4,263

 
$
2,975

Restricted Stock Units
$
835

 
$
502

 
$
1,255

Stock Option Awards
$
1,878

 
$
2,439

 
$
2,352

Schedule Of Equity Incentive Plan Disclosures
The following table summarizes our restricted stock activity, including performance restricted stock units, (in thousands, except per share amounts):
 
Shares
 
Weighted-
Average
Grant Date Fair
Value
Unvested balance at December 31, 2017
543

 
$
16.23

Granted
309

 
$
17.45

Vested
(184
)
 
$
17.62

Forfeited
(41
)
 
$
17.39

Unvested balance at December 31, 2018
627

 
$
17.14

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
The weighted-average assumptions used to measure stock options granted during 2018, 2017, and 2016 are presented below.
 
2018
 
2017
 
2016
Expected life from date of grant (years)
5.3
 
5.3
 
4.4
Expected volatility
36.2%
 
42.0%
 
39.8%
Expected dividend yield
—%
 
—%
 
—%
Risk-free interest rate
2.50%
 
1.97%
 
1.16%
Schedule of Share-based Compensation, Stock Options, Activity
The following table summarizes our stock option activity (in thousands, except per share amounts):
 
Number of Options
 
Weighted-Average
Exercise
Price
 
Weighted-Average
Remaining
Contractual
Term in Years
 
Aggregate
Intrinsic
Value
Outstanding balance at December 31, 2017
1,979

 
$
19.52

 
5.5
 
$
1,431

Issued
252

 
17.34

 
 
 
 
Outstanding balance at December 31, 2018
2,231

 
$
19.27

 
4.8
 
$

Exercisable, end of year
1,440

 
$
19.66

 
3.8
 
$